Stonepine Capital Management, LLC Opiant Pharmaceuticals, Inc. Transaction History

Stonepine Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $1.54 Million - $3.55 Million	152,278 New	152,278 $1.83 Million
Q2 2020 Aug 13, 2020	SELL	$8.64 - $11.87 $3.29 Million - $4.52 Million	-380,948 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$9.11 - $14.42 $425,218 - $673,067	46,676 Added 13.96%	380,948 $3.65 Million
Q4 2019 Feb 13, 2020	BUY	$13.16 - $15.96 $265,818 - $322,376	20,199 Added 6.43%	334,272 $4.81 Million
Q3 2019 Nov 13, 2019	SELL	$11.26 - $16.48 $15,707 - $22,989	-1,395 Reduced 0.44%	314,073 $4.73 Million
Q2 2019 Aug 13, 2019	BUY	$10.25 - $13.98 $210,883 - $287,624	20,574 Added 6.98%	315,468 $4.18 Million
Q1 2019 May 14, 2019	SELL	$13.02 - $15.94 $821,119 - $1.01 Million	-63,066 Reduced 17.62%	294,894 $3.87 Million
Q4 2018 Feb 13, 2019	BUY	$13.84 - $18.79 $2.38 Million - $3.23 Million	172,073 Added 92.57%	357,960 $5.17 Million
Q3 2018 Nov 13, 2018	BUY	$12.89 - $23.43 $2.4 Million - $4.36 Million	185,887 New	185,887 $3.32 Million

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.